Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 292

    1.

    The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes.

    Triplitt C, McGill JB, Porte D Jr, Conner CS.

    J Manag Care Pharm. 2007 Dec;13(9 Suppl C):S2-16; quiz S17. Review.PMID: 18062735 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

    Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

    Circulation. 2007 Jan 2;115(1):114-26. Epub 2006 Dec 27.PMID: 17192512 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

    Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association.

    Diabetes Care. 2007 Jan;30(1):162-72. Review.PMID: 17192355 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans.

    Porte D Jr, Baskin DG, Schwartz MW.

    Diabetes. 2005 May;54(5):1264-76. Review.PMID: 15855309 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Diabetes, obesity, and the brain.

    Schwartz MW, Porte D Jr.

    Science. 2005 Jan 21;307(5708):375-9.PMID: 15662002 [PubMed - indexed for MEDLINE]Related articles

    6.

    Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.

    Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R.

    Diabetes Care. 2004 Jan;27(1):256-63. Review. No abstract available. PMID: 14693998 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

    Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R; American Heart Association; American Diabetes Association.

    Circulation. 2003 Dec 9;108(23):2941-8. Review. No abstract available. PMID: 14662691 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Leptin and insulin action in the central nervous system.

    Porte D Jr, Baskin DG, Schwartz MW.

    Nutr Rev. 2002 Oct;60(10 Pt 2):S20-9; discussion S68-84, 85-7. Review.PMID: 12403080 [PubMed - indexed for MEDLINE]Related articles

    9.

    Expression of collagenase-3 (MMP-13) in c-fos-induced osteosarcomas and chondrosarcomas is restricted to a subset of cells of the osteo-/chondrogenic lineage.

    Tuckermann JP, Vallon R, Gack S, Grigoriadis AE, Porte D, Lutz A, Wagner EF, Schmidt J, Angel P.

    Differentiation. 2001 Dec;69(1):49-57.PMID: 11776394 [PubMed - indexed for MEDLINE]Related articles

    10.

    Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.

    Porte D Jr.

    Diabetes Metab Res Rev. 2001 May-Jun;17(3):181-8. Review.PMID: 11424231 [PubMed - indexed for MEDLINE]Related articles

    11.
    12.

    beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.

    Porte D Jr, Kahn SE.

    Diabetes. 2001 Feb;50 Suppl 1:S160-3. Review.PMID: 11272181 [PubMed - indexed for MEDLINE]Related articles

    13.

    Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity.

    Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D Jr.

    J Nutr. 2001 Feb;131(2):354S-60S. Review.PMID: 11160560 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Mechanisms for hyperglycemia in the metabolic syndrome. The key role of beta-cell dysfunction.

    Porte D Jr.

    Ann N Y Acad Sci. 1999 Nov 18;892:73-83. Review.PMID: 10842653 [PubMed - indexed for MEDLINE]Related articles

    15.

    Central nervous system control of food intake.

    Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG.

    Nature. 2000 Apr 6;404(6778):661-71. Review.PMID: 10766253 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comments on the relation among GAD-65, IA-2 antibodies and body adiposity.

    Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW.

    Diabetologia. 2000 Jan;43(1):134. No abstract available. PMID: 10672457 [PubMed - indexed for MEDLINE]Related articles

    17.

    Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight.

    Baskin DG, Figlewicz Lattemann D, Seeley RJ, Woods SC, Porte D Jr, Schwartz MW.

    Brain Res. 1999 Nov 27;848(1-2):114-23. Review.PMID: 10612703 [PubMed - indexed for MEDLINE]Related articles

    18.

    Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding.

    Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Porte D Jr, Schwartz MW.

    Am J Physiol. 1999 Oct;277(4 Pt 1):E659-67.PMID: 10516125 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The JIM interview. Daniel Porte, Jr, MD.

    Porte D Jr.

    J Investig Med. 1999 Mar;47(3):101-5. No abstract available. PMID: 10198564 [PubMed - indexed for MEDLINE]Related articles

    20.

    Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus.

    Baskin DG, Schwartz MW, Seeley RJ, Woods SC, Porte D Jr, Breininger JF, Jonak Z, Schaefer J, Krouse M, Burghardt C, Campfield LA, Burn P, Kochan JP.

    J Histochem Cytochem. 1999 Mar;47(3):353-62.PMID: 10026237 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone.

    Porte D, Tuckermann J, Becker M, Baumann B, Teurich S, Higgins T, Owen MJ, Schorpp-Kistner M, Angel P.

    Oncogene. 1999 Jan 21;18(3):667-78.PMID: 9989817 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    NPY and food intake: discrepancies in the model.

    Woods SC, Figlewicz DP, Madden L, Porte D Jr, Sipols AJ, Seeley RJ.

    Regul Pept. 1998 Sep 25;75-76:403-8. Review.PMID: 9802436 [PubMed - indexed for MEDLINE]Related articles

    23.

    Obesity, diabetes and the central nervous system.

    Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW.

    Diabetologia. 1998 Aug;41(8):863-81. Review. No abstract available. PMID: 9726588 [PubMed - indexed for MEDLINE]Related articles

    24.

    Signals that regulate food intake and energy homeostasis.

    Woods SC, Seeley RJ, Porte D Jr, Schwartz MW.

    Science. 1998 May 29;280(5368):1378-83. Review.PMID: 9603721 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus.

    Prigeon RL, Kahn SE, Porte D Jr.

    J Clin Endocrinol Metab. 1998 Mar;83(3):819-23.PMID: 9506734 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    A new LexA-based genetic system for monitoring and analyzing protein heterodimerization in Escherichia coli.

    Dmitrova M, Younès-Cauet G, Oertel-Buchheit P, Porte D, Schnarr M, Granger-Schnarr M.

    Mol Gen Genet. 1998 Jan;257(2):205-12.PMID: 9491079 [PubMed - indexed for MEDLINE]Related articles

    27.

    Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.

    Røder ME, Porte D Jr, Schwartz RS, Kahn SE.

    J Clin Endocrinol Metab. 1998 Feb;83(2):604-8.PMID: 9467581 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

    Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr.

    Neurology. 1998 Jan;50(1):164-8.PMID: 9443474 [PubMed - indexed for MEDLINE]Related articles

    29.

    Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms.

    Schwartz MW, Prigeon RL, Kahn SE, Nicolson M, Moore J, Morawiecki A, Boyko EJ, Porte D Jr.

    Diabetes Care. 1997 Sep;20(9):1476-81.PMID: 9283801 [PubMed - indexed for MEDLINE]Related articles

    30.

    DNA binding and transactivation properties of Fos variants with homodimerization capacity.

    Porte D, Oertel-Buchheit P, John M, Granger-Schnarr M, Schnarr M.

    Nucleic Acids Res. 1997 Aug 1;25(15):3026-33.PMID: 9304112 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Normal physiology and phenotypic characterization of beta-cell function in subjects at risk for non-insulin-dependent diabetes mellitus.

    Porte D Jr.

    Diabet Med. 1996 Sep;13(9 Suppl 6):S25-32. Review.PMID: 8894477 [PubMed - indexed for MEDLINE]Related articles

    32.

    Intraventricular neuropeptide Y does not stimulate food intake in the baboon.

    Sipols AJ, Figlewicz DP, Seeley RJ, Chavez M, Woods SC, Porte D Jr.

    Physiol Behav. 1996 Sep;60(3):717-9.PMID: 8873242 [PubMed - indexed for MEDLINE]Related articles

    33.

    Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus.

    Prigeon RL, Jacobson RK, Porte D Jr, Kahn SE.

    J Clin Endocrinol Metab. 1996 Sep;81(9):3295-8.PMID: 8784086 [PubMed - indexed for MEDLINE]Related articles

    34.

    Diabetes complications: why is glucose potentially toxic?

    Porte D Jr, Schwartz MW.

    Science. 1996 May 3;272(5262):699-700. Review. No abstract available. Erratum in: Science 1996 Jun 28;272(5270):1861. PMID: 8614830 [PubMed - indexed for MEDLINE]Related articles

    35.

    Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans.

    Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr.

    Nat Med. 1996 May;2(5):589-93.PMID: 8616722 [PubMed - indexed for MEDLINE]Related articles

    36.

    Endocrine regulation of food intake and body weight.

    Figlewicz DP, Schwartz MW, Seeley RJ, Chavez M, Baskin DG, Woods SC, Porte D Jr.

    J Lab Clin Med. 1996 Apr;127(4):328-32. Review. No abstract available. PMID: 8656034 [PubMed - indexed for MEDLINE]Related articles

    37.

    Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.

    Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D Jr, Woods SC, Seeley RJ, Weigle DS.

    Diabetes. 1996 Apr;45(4):531-5.PMID: 8603777 [PubMed - indexed for MEDLINE]Related articles

    38.

    A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men.

    Stone LM, Kahn SE, Fujimoto WY, Deeb SS, Porte D Jr.

    Diabetes. 1996 Apr;45(4):422-8.PMID: 8603762 [PubMed - indexed for MEDLINE]Related articles

    39.

    The effect of epinephrine on immunoreactive insulin levels in man: 1965.

    Porte D Jr, Graber AL, Kuzuya T, Williams RH.

    Nutrition. 1996 Mar;12(3):225-6; discussion 224, 226. No abstract available. PMID: 8798235 [PubMed - indexed for MEDLINE]Related articles

    40.

    Report of the American Diabetes Association's Task Force on standardization of the insulin assay.

    Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, Gingerich R, Goldstein D, Widemeyer HM, Haffner S, Hales CN, Jarett L, Polonsky K, Porte D, Skyler J, Webb G, Gallagher K.

    Diabetes. 1996 Feb;45(2):242-56.PMID: 8549870 [PubMed - indexed for MEDLINE]Related articles

    41.

    The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans.

    Prigeon RL, Røder ME, Porte D Jr, Kahn SE.

    J Clin Invest. 1996 Jan 15;97(2):501-7.PMID: 8567973 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans.

    Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte D Jr, Robertson RP.

    J Clin Invest. 1996 Jan 15;97(2):455-60.PMID: 8567967 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    The evaluation of insulin as a metabolic signal influencing behavior via the brain.

    Woods SC, Chavez M, Park CR, Riedy C, Kaiyala K, Richardson RD, Figlewicz DP, Schwartz MW, Porte D Jr, Seeley RJ.

    Neurosci Biobehav Rev. 1996;20(1):139-44. Review.PMID: 8622820 [PubMed - indexed for MEDLINE]Related articles

    44.

    Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs.

    Baura GD, Foster DM, Kaiyala K, Porte D Jr, Kahn SE, Schwartz MW.

    Diabetes. 1996 Jan;45(1):86-90.PMID: 8522065 [PubMed - indexed for MEDLINE]Related articles

    45.

    Changes in insulin sensitivity, glucose effectiveness, and B-cell function in regularly exercising subjects.

    Prigeon RL, Kahn SE, Porte D Jr.

    Metabolism. 1995 Oct;44(10):1259-63.PMID: 7476281 [PubMed - indexed for MEDLINE]Related articles

    46.

    Fos leucine zipper variants with increased association capacity.

    Porte D, Oertel-Buchheit P, Granger-Schnarr M, Schnarr M.

    J Biol Chem. 1995 Sep 29;270(39):22721-30.PMID: 7559397 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    The key role of islet dysfunction in type II diabetes mellitus.

    Porte D Jr, Kahn SE.

    Clin Invest Med. 1995 Aug;18(4):247-54. Review.PMID: 8549009 [PubMed - indexed for MEDLINE]Related articles

    48.

    Intraventricular insulin enhances the meal-suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon.

    Figlewicz DP, Sipols AJ, Seeley RJ, Chavez M, Woods SC, Porte D Jr.

    Behav Neurosci. 1995 Jun;109(3):567-9.PMID: 7662167 [PubMed - indexed for MEDLINE]Related articles

    49.

    Glucokinase gene variations in Japanese-Americans with a family history of NIDDM.

    Stone LM, Kahn SE, Deeb SS, Fujimoto WY, Porte D Jr.

    Diabetes Care. 1994 Dec;17(12):1480-3.PMID: 7882822 [PubMed - indexed for MEDLINE]Related articles

    50.

    Reliability of error estimates from the minimal model: implications for measurements in physiological studies.

    Prigeon RL, Kahn SE, Porte D Jr.

    Am J Physiol. 1994 Feb;266(2 Pt 1):E279-86.PMID: 8141288 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...